Page 166 - 80 guidelines for the treatment of malaria_opt
P. 166

nd
              Guidelines for the treatment of malaria – 2  edition


            a7.4  references


            1.   Sinclair D et al. Artemisinin-based combination therapy for treating uncomplicated
                 malaria. Cochrane Database of Systematic Reviews, 2009:CD007483.
            2.   Zongo I et al. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine,
                 artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of
                 uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clinical Infectious
                 Diseases, 2007, 45:1453–1461.
            3.   Karema C et al. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for
                 the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
                 Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006, 100:1105–1111.
            4.   Faye B et al.  Efficacy and tolerability of four antimalarial combinations in the treatment of
                 uncomplicated Plasmodium falciparum malaria in Senegal. Malaria Journal, 2007, 6:80.
            5.   Fanello CI et al. A randomised trial to assess the safety and efficacy of artemether-
                 lumefantrine (Coartem®) for the treatment of uncomplicated Plasmodium falciparum
                 malaria in Rwanda. Transactions of the Royal Society of Tropical Medicine and Hygiene,
                 2007, 101:344–350.
            6.   Dorsey G et al. Combination therapy for uncomplicated falciparum malaria in Ugandan
                 children: a randomized trial. Journal of the American Medical Association, 2007, 297:2210–
                 2219.
            7.   Zongo I et al. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine
                 for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
                 Lancet, 2007, 369:491–498.
            8.   Menard  D  et  al.  Randomized  clinical  trial  of  artemisinin  versus  non-artemisinin
                 combination therapy for uncomplicated falciparum malaria in Madagascar. Malaria
                 Journal, 2007, 6:65.
            9.   Yeka A et al. Artemisinin versus nonartemisinin combination therapy for uncomplicated
                 malaria: randomized clinical trials from four sites in Uganda. PLoS Medicine, 2005,
                 2:e190.
            10.   Adjuik M et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet,
                 2004, 363:9–17.
            11.   Janssens B et al.  A randomized open study to assess the efficacy and tolerability of
                 dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria
                 in Cambodia. Tropical Medicine and International Health, 2007, 12:251–259.
            12.  Ashley EA et al. Randomized, controlled dose-optimization studies of dihydroartemisinin-
                 piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in
                 Thailand. Journal of Infectious Diseases, 2004, 190:1773–1782.
            13.   Ashley EA et al. Randomized, controlled study of a simple, once-daily regimen of
                 dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant
                 falciparum malaria. Clinical Infectious Diseases, 2005, 41:425–432.




   152
   161   162   163   164   165   166   167   168   169   170   171